文献速递神经肿瘤

激光间质热疗作为深部不可及胶质瘤的主要治疗

Laser Interstitial Thermal Therapy as a Primary Treatment for Deep Inaccessible Gliomas.
PubMed 文献 · Neurosurgery · 2019-01-01

该研究报道单中心单术者2010至2017年收治的74例接受激光间质热疗(LITT)的患者,其中对6例深部胶质瘤患者(平均肿瘤体积10.9 cc,范围4.2-52 cc)同期行活检与激光消融进行探索性队列分析;术后MRI平均消融范围(EOA)为98.5%,平均无进展生存期14.3个月,5例(83%)在平均19.7个月随访时无并发症存活;作者认为LITT可作为深部手术不可及胶质瘤的安全替代减瘤治疗。

要点

  • 6例深部胶质瘤患者接受同期活检与LITT,平均肿瘤体积10.9 cc(范围4.2-52 cc)。
  • 术后MRI平均消融范围(EOA)为98.5%,平均无进展生存期14.3个月。
  • 5例(83%)在平均19.7个月随访时无并发症存活;作者建议LITT可作为安全替代减瘤治疗。

核心结论

  • 作者认为尽管系列样本小,LITT可作为深部手术不可及胶质瘤的安全替代减瘤治疗。
  • 作者相信若患者选择合适,LITT可能改善这些患者的生存并补充辅助治疗。

研究设计与样本

  • 探索性队列研究,2010至2017年从单中心单术者收治的74例接受LITT的患者中,纳入6例同期行活检与激光消融的深部胶质瘤患者。
  • 6例患者平均肿瘤体积10.9 cc(范围4.2-52 cc)。

主要发现

  • 术后MRI平均消融范围(EOA)为98.5%。
  • 平均无进展生存期为14.3个月。
  • 5例(83%)在平均随访19.7个月时存活且无并发症。
  • 与既往报道系列分析时,术前病灶大小与EOA呈负线性关系(P < .04)。

临床怎么用

  • 作者建议LITT可作为深部手术不可及胶质瘤的安全替代减瘤治疗。
  • 作者认为若患者选择合适,LITT可能改善这些患者的生存并补充辅助治疗。

局限性

  • 作者指出其系列样本小。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Treatment strategies for deep intracranial gliomas remain limited to stereotactic biopsy in many cases due to the morbidity of aggressive surgical resection. Since no cytoreductive therapy is offered, outcomes have been demonstrably poor compared to patients who are able to undergo primary surgical resection. OBJECTIVE: To present our practice, in an effort to reduce morbidity and still offer cytoreductive treatment, of offering the possibility of laser interstitial thermal therapy (LITT) for the primary treatment of intracranial deep gliomas that would be otherwise unamenable for resection. METHODS: From 2010 to 2017, 74 patients were identified from a single surgeon at a single tertiary care referral center who had been treated with LITT. We conducted an exploratory cohort study on patients (n = 6) who have undergone contemporaneous biopsy and laser ablation for the treatment of deep gliomas with a mean tumor volume of 10.9 cc (range 4.2-52 cc). RESULTS: In our cohort, mean extent of ablation (EOA) was 98.5% on postoperative MRI; mean progression-free survival was 14.3 mo, and 5 patients (83%) remained alive at mean follow-up time of 19.7 mo without any complications. Additionally, there was a negative linear relationship between preoperative lesion size and EOA (P < .04) when analyzed with previously reported series. CONCLUSION: Although our series is small, we suggest that LITT can be a safe alternative cytoreductive therapy for deep surgically inaccessible gliomas. Given the known benefit of near gross total resection for high-grade gliomas, we believe LITT may improve survival for these patients and complement adjuvant treatments if patients are appropriately selected.

来源:Neurosurgery,查看原文。版权归原作者所有。

引用

  1. Shah AH, Burks JD, Buttrick SS, et al. Laser Interstitial Thermal Therapy as a Primary Treatment for Deep Inaccessible Gliomas. Neurosurgery. 2019. PMID: 29873756. doi:10.1093/neuros/nyy238

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。